Identifying human cancers to target with BCL-2 inhibition
Side effects of novel PI3K inhibitors
Panel discussion on T-cell lymphoma: current status of therapy and progress
Elaine Jaffe et al.
The importance of diagnosing DLBCL on a molecular level and how it will improve treatment
Copanlisib produces promising results in relapsed/refractory follicular lymphoma